Invivyd, Inc.
VYD2311
COVID
Countdown
86days
Phase 3 readout · ~ Sep 30, 2026 estimated
What's at stake
Phase 3 trial results for VYD2311 in COVID are due ~ Sep 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 11h ago
“Topline data now expected Q3 2026, dependent on enrollment; updates to be provided”